lcp
We have detected you are using Internet Explorer. To provide the best and most secure experience, please use a modern browser as we do not support Internet Explorer.

Non-adherence to thromboprophylaxis prescribing in general practice – the views of GPs

27 January 2022 - Eyob Gebreyohannes

Last year, I conducted a series of interviews with GPs in order to understand their experiences with anticoagulation management in patients with atrial fibrillation (AF). It is well known that AF is the most common arrhythmia seen in Australian general practice, and that the use of anticoagulants is a well-established intervention to reduce the risk of thromboembolism. This is reflected in the 2018 National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand AF guidelines

As such, I wanted to know more about GPs’ experiences with anticoagulation, and any barriers they may have with initiating anticoagulation. Below is what I found out from the research study: 

  • Clinical practice guidelines, including the AF guidelines above, were not the primary sources of information on thromboprophylaxis in AF. Clinical guidelines were regarded as bulky and time consuming, and focus on single disease conditions, making it challenging to readily apply them.
  • Instead, educational activities and concise resources such as journal articles and guideline summary documents were regarded as more useful means of keeping up to date with current recommendations.
  • Balancing the thromboprophylactic benefits of oral anticoagulants with their bleeding risk was a major challenge in prescribing decisions.
  • When compared to using formal stroke risk assessment tools like the CHA2DS2-VA, a major gap existed in applying formal bleeding risk assessment tools e.g. HAS-BLED. Instead, bleeding risk assessment was mainly done based on clinical assessment.
  • In terms of bleeding risk, aspirin was seen as a safer option to oral anticoagulants by some GPs, 
  • Access to a cardiologist can sometimes be challenging, especially through the public system.
  • Patients’ refusal to take oral anticoagulants can sometimes affect prescribing decisions.

For more information, see the published paper 

If you are interested in the latest clinical updates on AF, and multiple other general practice topics, join us in February for our signature CPD program, the 2022 version of Hot Topics GP Update course.

Eyob Gebreyohannes (PhD candidate at the University of Western Australia – Optimising anticoagulation in atrial fibrillation in Australian general practice setting.)

Email: eyob.gebreyohannes@research.uwa.edu.au

Eyob Gebreyohannes
Eyob Gebreyohannes

BPharm, MSc, Ph.D. Candidate

Division of Pharmacy • School of Allied Health

Faculty of Health and Medical Sciences, University of Western Australia 

Get Medcast Plus

Become a member and get unlimited access to 100s of hours of premium education.

Learn more
Related News
Non-invasive prenatal testing/screening (NIPT/S) - clinical fact sheet and MCQ

PRECISE Education Team

Brand icon

An increasing number of pregnant patients are seeking advice from their GP about prenatal genetic testing. This FastTrack covers non-invasive prenatal testing/screening, including how it works, indications, limitations, and different types of testing panels. 30mins each of RP and EA CPD available.

10 mins READ
Wearables and AF: how smart are smartwatches?

Quality Use of Medicines Alliance

Brand icon

Wearables with PPG or ECG capabilities can identify episodes of irregular heart rhythms suggestive of AF, but should not replace traditional methods of diagnosis, such as a 12-lead ECG. Evidence of accuracy and positive predictive values from prospective, comparative trials involving older populations are limited, and the potential for inconclusive results remains a concern based on current trial findings. Their utility may be highest for symptomatic individuals or those at risk of developing AF.

10 mins READ
Reproductive genetic carrier screening - clinical fact sheet and MCQ

PRECISE Education Team

Brand icon

Reproductive genetic carrier screening (RGCS) may be considered for patients during their preconception counselling stage. This FastTrack covers who should be offered RGCS, which conditions it screens for, and what to do with the results. 30mins each of RP and EA CPD available.

10 mins READ